Back
Novo Integrated Sciences Vs. P3 Health Partners Industry Stock Comparison
Sell
50
NVOS
Novo Integrated Sciences
Last Price:
0.19
Seasonality Move:
-18.86%
Sell
21
PIII
P3 Health Partners
Last Price:
0.36
Seasonality Move:
-47.47%
Sell
50
Novo Integrated Sciences (NVOS)
is a Sell
Is Novo Integrated Sciences a Buy, Sell or Hold?
- The current Novo Integrated Sciences [NVOS] share price is $0.20. The Score for NVOS is 50, which is 0% below its historic median score of 50, and infers higher risk than normal.
- NVOS is currently trading in the 40-50% percentile range relative to its historical Stock Score levels.
- This Score is currently showing a lower than normal reading, suggesting risk levels may be somewhat higher than normal and additional caution is warranted.
Sell
21
P3 Health Partners (PIII)
is a Sell
Is P3 Health Partners a Buy, Sell or Hold?
- The current P3 Health Partners [PIII] share price is $0.38. The Score for PIII is 21, which is 58% below its historic median score of 50, and infers higher risk than normal.
- PIII is currently trading in the 20-30% percentile range relative to its historical Stock Score levels.
- This Score is currently showing a lower than normal reading, suggesting risk levels may be somewhat higher than normal and additional caution is warranted.
NVOS Stock Price Chart
What is Novo Integrated Sciences's stock price today?
-
The Novo Integrated Sciences share price today is $0.20
Based on the share price being below its 5, 20 & 50 day exponential moving averages, the current trend is considered strongly bearish and NVOS is experiencing buying pressure, which is a positive indicator for future bullish movement.
PIII Stock Price Chart
What is P3 Health Partners's stock price today?
-
The P3 Health Partners share price today is $0.38
Based on the share price being below its 5, 20 & 50 day exponential moving averages, the current trend is considered strongly bearish and PIII is experiencing slight selling pressure.
NVOS Technical Analysis
| Chart Indicators | Level | Buy or Sell |
|---|---|---|
| MACD (12, 26): | -0.03 | Sell |
| Relative Strength Index (14 RSI): | 33 | Sell |
| Chaikin Money Flow: | -19052 | - |
| Bollinger Bands | Level | Buy or Sell |
|---|---|---|
| Bollinger Bands (25): | (0.22 - 0.28) | Sell |
| Bollinger Bands (100): | (0.25 - 0.71) | Sell |
PIII Technical Analysis
| Chart Indicators | Level | Buy or Sell |
|---|---|---|
| MACD (12, 26): | -0.01 | Sell |
| Relative Strength Index (14 RSI): | 43.96 | Sell |
| Chaikin Money Flow: | -208645 | - |
| Bollinger Bands | Level | Buy or Sell |
|---|---|---|
| Bollinger Bands (25): | (0.34 - 0.42) | Sell |
| Bollinger Bands (100): | (0.41 - 0.59) | Sell |
NVOS Moving Averages
| Moving Averages | Level | Buy or Sell |
|---|---|---|
| 8-day SMA: | 0.21 | Sell |
| 20-day SMA: | 0.24 | Sell |
| 50-day SMA: | 0.28 | Sell |
| 200-day SMA: | 0.55 | Sell |
| 8-day EMA: | 0.21 | Sell |
| 20-day EMA: | 0.24 | Sell |
| 50-day EMA: | 0.31 | Sell |
| 200-day EMA: | 0.73 | Sell |
PIII Moving Averages
| Moving Averages | Level | Buy or Sell |
|---|---|---|
| 8-day SMA: | 0.42 | Sell |
| 20-day SMA: | 0.38 | Sell |
| 50-day SMA: | 0.43 | Sell |
| 200-day SMA: | 0.68 | Sell |
| 8-day EMA: | 0.4 | Sell |
| 20-day EMA: | 0.4 | Sell |
| 50-day EMA: | 0.44 | Sell |
| 200-day EMA: | 0.75 | Sell |
Novo Integrated Sciences Earnings Growth & NVOS Earnings Dates
- Analysts estimate an earnings decrease this quarter of $0.00 per share, a decrease next quarter of $0.00 per share, a decrease this year of $0.00 per share, and a decrease next year of $0.00 per share.
P3 Health Partners Earnings Growth & PIII Earnings Dates
- Analysts estimate an earnings increase this quarter of $0.00 per share, a decrease next quarter of $0.00 per share, an increase this year of $0.06 per share, and an increase next year of $0.14 per share.
Novo Integrated Sciences Technical Analysis
| Oct 16 | Oct 18 | Oct 21 | Oct 22 | Oct 23 | Oct 24 | Oct 25 | Oct 28 | Oct 29 | Oct 30 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Oct | ||||||||||
| 16 | 18 | 21 | 22 | 23 | 24 | 25 | 28 | 29 | 30 | |
| Technical Analysis: Buy or Sell? | ||||||||||
| 8-day SMA: | ||||||||||
| 20-day SMA: | ||||||||||
| 50-day SMA: | ||||||||||
| 200-day SMA: | ||||||||||
| 8-day EMA: | ||||||||||
| 20-day EMA: | ||||||||||
| 50-day EMA: | ||||||||||
| 200-day EMA: | ||||||||||
| MACD (12, 26): | ||||||||||
| Relative Strength Index (14 RSI): | ||||||||||
| Bollinger Bands (25): | ||||||||||
| Bollinger Bands (100): | ||||||||||
P3 Health Partners Technical Analysis
| Oct 16 | Oct 18 | Oct 21 | Oct 22 | Oct 23 | Oct 24 | Oct 25 | Oct 28 | Oct 29 | Oct 30 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Oct | ||||||||||
| 16 | 18 | 21 | 22 | 23 | 24 | 25 | 28 | 29 | 30 | |
| Technical Analysis: Buy or Sell? | ||||||||||
| 8-day SMA: | ||||||||||
| 20-day SMA: | ||||||||||
| 50-day SMA: | ||||||||||
| 200-day SMA: | ||||||||||
| 8-day EMA: | ||||||||||
| 20-day EMA: | ||||||||||
| 50-day EMA: | ||||||||||
| 200-day EMA: | ||||||||||
| MACD (12, 26): | ||||||||||
| Relative Strength Index (14 RSI): | ||||||||||
| Bollinger Bands (25): | ||||||||||
| Bollinger Bands (100): | ||||||||||